Long‐Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis

OBJECTIVE: The present study was undertaken to conduct a phase IV, open‐label, prospective study to characterize the long‐term safety of rituximab in a 4‐year observational registry of adult patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA) within the US. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Merkel, Peter A., Niles, John L., Mertz, Lester E., Lehane, Patricia B., Pordeli, Pooneh, Erblang, Félix, Allen, Nancy, Block, Joel A., Cartin‐Ceba, Rodrigo, Koening, Curry, Langford, Carol, Monach, Paul, Moreland, Larry W., Nachman, Patrick, Wallace, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Vasculitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457173/
https://www.ncbi.nlm.nih.gov/pubmed/32475029
http://dx.doi.org/10.1002/acr.24332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457173/
https://www.ncbi.nlm.nih.gov/pubmed/32475029
http://dx.doi.org/10.1002/acr.24332

Ejemplares similares